The web-based interactive Costing Tool (iCT) provides a framework for transparent cost display and calculation to support swift local site budget negotiations when planning commercial trials in the NHS.
This digital version of the iCT enables even faster costing and contracting between the life sciences industry and the NHS as part of the study set-up phase. The tool is available as a module within the NIHR Central Portfolio Management System (CPMS) and includes a number of major improvements.
The information on this page will signpost you to all the available guidance you need to begin using the iCT.
How we use the iCT is changing from October:
The following animation provides an overview of the iCT and its role in supporting a UK National Contract Value Review Process from October. Find out more about this change on the NHS England website.
You can also view some helpful infographics which summarise some of the main features of the new UK national contract value review process.
- How the national review supports commercial research set-up and where this process fits in terms of overall activities (Infogram)
- How the costing tool user roles support partnership working and enable a UK national contract value review (Infogram)
- Explanations of the key responsibilities for all three user roles - including some handy top tips
- iCT and Study Resource Review (Infogram)
Employees of life sciences companies and contract research organisations may find the infographic describing the Company Representative iCT User Role Profile (Infogram) useful.
Why use the iCT?
With improved usability, functionality, reliability and compatibility the CPMS-based system makes it quicker and easier to set up commercial studies in the NHS through increased accuracy and visibility of commercial costing. The iCT underpins the transition to a single review process for all commercial studies - minimising the time required to negotiate the cost for delivering research at an individual site.
Here are some iCT functionality improvements at a glance:
The web-based iCT works on any computer - overcoming software compatibility issues with the previous Excel-based version of the tool
With a simple layout, the iCT is a fully automated costing solution - accessible from the NIHR Central Portfolio Management System (CPMS)
Updates or changes to the system are now a seamless process, improving system reliability
- Improved audit functionality
The iCT app contains a central log of all adjustments made as part of the contract negotiation process - enabling NIHR to further streamline processes by identifying any issues or delays
It enables resource requirements determined at a site level to be shared with others involved in the study within the system, avoiding duplication of effort.
What you need to use the system
- You will need a Central Portfolio Management System (CPMS) account to use the interactive Costing Tool. This is available via individual or group email addresses (multiple uses of the same group log-in can be used via an ‘incognito’ or ‘private’ browser window). To create an account, follow the ‘Create an Account’ button on the CPMS homepage.
- We suggest that all users of iCT in CPMS view all of the instructional videos as they clearly link the various stages of iCT completion as it moves through the CPMS system. See ‘Video Tutorials’ below.
- You will also need a copy of the protocol and other study documentation or information relevant to understanding the resource requirements for the study, ideally reflecting the versions planned for submission with your study approvals.
- To submit your iCT for review by the NHS, you will need to know your Chief Investigator location. Our support services can help you find one.
Where the data comes from
- Review of the site Market Forces Factor by NHSE/I annually
- Annual Salaries from NHS Employers including prospective uplifts
- Apprenticeship Levy from NHS Employers 0.5%PA for all NHS gross pay costs
- Investigation cost baselining via Specialist Working Groups at senior Institute Level (e.g. Royal College of Pathology, Royal Institute of Ophthalmology) via the NIHR Costing Models Working Group
- NHS Inflator value from NHSE of 2% PA used to inflate investigation costs on an annual basis.
Guidance and supporting information
- Frequently Asked Questions (FAQs)
- interactive Costing Tool tariff data 2022 to 2023 (.XLSX - Excel)
National tariff workbooks within a single Excel file. Contains data for the following:
- 2022 Investigation and Intervention Tariff
- Departmental, Set Up and Closedown Tariff 2022/23
- Procedures Definitions and Tariff 2022/23
- NHSE/I Market Forces Factor 2022-23
- NCVR Commitment to adhere to the organisation specific iCT generated prices.
- Video tutorials
A number of helpful films on using the iCT are available on our NIHRtv Youtube channel, including an introduction to iCT study submissions and assigning your costing to an NHS site.
The above videos are intended as system guidance - therefore it is not possible to include an audio description of every action. If you require further support, or the same information in an alternative format, please contact firstname.lastname@example.org
- The following costing guidance from DMD hub will help sites and companies cost Duchenne Muscular Dystrophy studies more effectively when using the iCT.
In response to feedback from users, a number of changes have been made in the iCT:
- The availability of a ‘Setup & Close-down’ separate to the per-participant budget at the study level. This allows Company Representatives to add generic Setup & Close-down activities to the iCT from the start of their submission, rather than only at the site level following validation.
- The ability for Company Representatives to add Site Representatives to the iCT themselves.
- The ability for Company Representatives to preview site costs before releasing to Site Representatives.
- The ability to mark a Site iCT as ‘Complete’ to indicate that the review of the site costs has been completed.
- The ability to be able to change the status of a ‘Complete’ Site iCT to allow amendments to be made.
- The ability for Company Representatives to Delete a Site iCT at any stage of the review process. Allowing Company Representatives to ‘re-release’ a Site iCT (by deleting and creating again) when an amendment is made in a Study-level iCT so that these changes will also be reflected in the Site iCT. Rather than having to update each Site iCT with the same amendment individually.
- The ability for users to add new occurrences/activity counts for an existing activity/visit without having to enter a free text comment, reducing the number of clicks and saving users time completing or reviewing the iCT.
- The ability for a user to add new visits/activities and their associated occurrences/activity counts with only one comment.
- The ability for users to view and accept grouped comments with one click.
Functionality improvements to the iCT continue to be released with the next development focusing on reducing the ‘multiple clicks’ within the system. Future development will include functionality to manage inflation change for contracted studies and a mechanism for prioritisation of future user feedback is now in place to encourage the sharing of user improvement suggestions.
Please submit your comments and suggestions for the future development of the iCT via our feedback form.
Where can I get more advice or support
For general queries please contact email@example.com
If you are seeking support at a local level in relation to a particular site please contact your Local Clinical Research Network.